Edwin Rock
Technik-/Wissenschafts-/F&E-Leiter bei GLYCOMIMETICS, INC.
Vermögen: 641 939 $ am 30.04.2024
Profil
Edwin P.
Rock is currently the Chief Medical Officer & Senior Vice President at GlycoMimetics, Inc. Prior to this, he worked as the Chief Medical Officer at Partner Therapeutics, Inc. Dr. Rock received his undergraduate degree from Swarthmore College and his doctorate from Stanford University School of Medicine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GLYCOMIMETICS, INC.
0,58% | 15.03.2024 | 375 403 ( 0,58% ) | 641 939 $ | 30.04.2024 |
Aktive Positionen von Edwin Rock
| Unternehmen | Position | Beginn |
|---|---|---|
| GLYCOMIMETICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 06.09.2022 |
Ehemalige bekannte Positionen von Edwin Rock
| Unternehmen | Position | Ende |
|---|---|---|
Partner Therapeutics, Inc.
 Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Edwin Rock
| Swarthmore College | Undergraduate Degree |
| Stanford University School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GLYCOMIMETICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Partner Therapeutics, Inc.
Partner Therapeutics, Inc. BiotechnologyHealth Technology Partner Therapeutics, Inc. develops and commercializes therapeutics that improves health and economic outcomes in the treatment of cancer. Its development focus spans the entire range of cancer therapy from primary treatments to supportive care. The company is headquartered in Boston, MA. | Health Technology |
